Access practice tools, as well as industry leading news, customizable alerts, dockets, and primary content, including a comprehensive collection of case law, dockets, and regulations. Leverage...
Patent Trial and Appeal Board Chief Judge David P. Ruschke is stepping down to become a special adviser to the U.S. Patent and Trademark Office’s patent division, according to an agency email obtained by Bloomberg Law.
Deputy Chief Scott R. Boalick will be acting chief judge once Ruschke leaves office Sept. 2 until a new chief judge is appointed, agency director Andrei Iancu said in an internal email to employees. Vice Chief Judge Jacqueline Bonilla will be acting deputy chief, Iancu said in his email. The patent office declined to comment on the PTAB leadership change.
The shake-up comes as Iancu is pushing to change an administrative system that allows parties to challenge the validity of patents without going to federal court. The board hears such challenges, which are popular among tech companies such as Apple Inc. that are frequent targets of patent lawsuits, but unpopular among drugmakers such as AbbVie Inc. that rely on patents to fend off competitors.
Ruschke’s successor will play a major role in implementing any changes to the PTAB’s administrative patent challenge process.
Iancu told agency employees he wants better collaboration between the Office of the Commissioner for Patents, which examines and grants patent applications, and the PTAB, which hears administrative validity challenges to issued patents.
“While the PTAB and Patents have worked closely together to provide high-quality patent services, establishing a more direct channel between the business units will improve the free flow of information,” Iancu wrote in his email.
Ruschke will work closely with the PTAB, Iancu said. “David’s appointment to his new role is one development I believe will help our office provide and sustain a reliable patent system,” Iancu said.
Ruschke and Boalick didn’t immediately respond to Bloomberg Law requests for comment.
Ruschke was a former chief patent counsel for medical device company Medtronic’s coronary and structural heart unit before joining the PTAB as chief judge in May 2016. He was previously a patent attorney for Covington & Burling LLP.
Congress created the PTAB in a 2011 patent overhaul law as a specialized tribunal where anyone can challenge the validity of a patent. Lawmakers created the board as a quicker, lower-cost alternative to challenging patents in federal district courts.
The PTO, under Iancu’s watch has been examining PTAB procedures, such as the board’s decision-making process and the procedures for amending claims in patent challenges.
The agency proposed new rules in May that, which if enacted would require the PTAB to interpret patent claims at the same stringent levels as do federal courts and the International Trade Commission. The PTAB applies the broadest reasonable interpretation standard in patent challenges to consider claims that define the limits of a patented invention. The courts and commission’s narrower Phillips standard will interpret a claim’s “plain and ordinary meaning,” as it would be read by a “person of ordinary skill in the art at the time of invention.”
The board’s prominence has grown amid controversy over the patent challenge system. It has 265 judges.
U.S. patent owners, including independent inventors and pharmaceutical companies, complain that their patents can be killed patents easily through PTAB challenges. But tech companies and startups worry that changing the PTAB process would make it harder for them to fend off patent litigation.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)